ArticleOncoTargets and therapy2016

miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22.

Jianyong Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.